SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 13G/A

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

 

(Amendment No. 2)

 

Champions Oncology, Inc.

 

(Name of Issuer)

 

Common Stock

 

(Title of Class of Securities)

 

15870P307

 

(CUSIP Number)

 

September 30, 2024

 

(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[  ]Rule 13d-1(b)
[X]Rule 13d-1(c)
[  ]Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

(Continued on following pages) 

 

 

CUSIP NO. 15870P307

 13G Page 2 of 9 Pages

 

1

NAMES OF REPORTING PERSONS

 

WEST ELK PARTNERS, LP

  
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY

 

  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

STATE OF DELAWARE, UNITED STATES OF AMERICA

  

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

 5

SOLE VOTING POWER

 

N/A

  
6

SHARED VOTING POWER

 

882,581 shares of Common Stock

  
7

SOLE DISPOSITIVE POWER

 

N/A

  
8

SHARED DISPOSITIVE POWER

 

882,581 shares of Common Stock

  

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

882,581 shares of Common Stock

  
10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

[  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.49% of the outstanding shares of Common Stock

  
12

TYPE OF REPORTING PERSON

 

PN (Limited Partnership)

  

 

 

CUSIP NO. 15870P307

 13G Page 3 of 9 Pages

 

1

NAMES OF REPORTING PERSONS

 

WEST ELK, LLC

  
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY

 

  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

STATE OF DELAWARE, UNITED STATES OF AMERICA

  

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

 5

SOLE VOTING POWER

 

N/A

  
6

SHARED VOTING POWER

 

882,581 shares of Common Stock

  
7

SOLE DISPOSITIVE POWER

 

N/A

  
8

SHARED DISPOSITIVE POWER

 

882,581 shares of Common Stock

  

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

882,581 shares of Common Stock

  
10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

[  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.49% of the outstanding shares of Common Stock

  
12

TYPE OF REPORTING PERSON

 

OO (Limited Liability Company)

  

 

 

CUSIP NO. 15870P307

 13G Page 4 of 9 Pages

 

1

NAMES OF REPORTING PERSONS

 

WEST ELK CAPITAL, LLC

  
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY

 

  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

STATE OF DELAWARE, UNITED STATES OF AMERICA

  

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

 5

SOLE VOTING POWER

 

N/A

  
6

SHARED VOTING POWER

 

882,581 shares of Common Stock

  
7

SOLE DISPOSITIVE POWER

 

N/A

  
8

SHARED DISPOSITIVE POWER

 

882,581 shares of Common Stock

  

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

882,581 shares of Common Stock

  
10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

[  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.49% of the outstanding shares of Common Stock

  
12

TYPE OF REPORTING PERSON

 

OO (Limited Liability Company), IA (Investment Adviser)

  

 

 

CUSIP NO. 15870P307

 13G Page 5 of 9 Pages

 

1

NAMES OF REPORTING PERSONS

 

Jason Joffe

  
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY

 

  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

UNITED STATES OF AMERICA

  

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

 5

SOLE VOTING POWER

 

N/A

  
6

SHARED VOTING POWER

 

882,581 shares of Common Stock

  
7

SOLE DISPOSITIVE POWER

 

N/A

  
8

SHARED DISPOSITIVE POWER

 

882,581 shares of Common Stock

  

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

882,581 shares of Common Stock

  
10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

[  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.49% of the outstanding Common Stock

  
12

TYPE OF REPORTING PERSON

 

IN (Individual)

  

 

 

CUSIP NO. 15870P307

 13G Page 6 of 9 Pages

 

1

NAMES OF REPORTING PERSONS

 

Morgan Duke

  
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY

 

  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

UNITED STATES OF AMERICA

  

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

 5

SOLE VOTING POWER

 

N/A

  
6

SHARED VOTING POWER

 

882,581 shares of Common Stock

  
7

SOLE DISPOSITIVE POWER

 

N/A

  
8

SHARED DISPOSITIVE POWER

 

882,581 shares of Common Stock

  

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

882,581 shares of Common Stock

  
10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

[  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.49% of the outstanding Common Stock

  
12

TYPE OF REPORTING PERSON

 

IN (Individual)

  

 

 

Item 1.(a) Name of Issuer:

 

Champions Oncology, Inc. (the “Issuer”)

 

(b)Address of Issuer’s Principal Executive Offices:

 

One University Plaza

Suite 307

Hackensack, New Jersey 07601

 

Item 2.(a) Name of Persons Filing:

 

West Elk Partners, LP

West Elk, LLC

West Elk Capital, LLC

Jason Joffe

Morgan Duke

 

(b)Address of Principal Business Office or, if None, Residence:

 

For all persons filing:

 

1175 Peachtree Street NE

Suite 360

Atlanta, GA 30361

 

(c)Citizenship:

 

West Elk Partners, LP is a Delaware limited partnership

West Elk, LLC is a Delaware limited liability company

West Elk Capital, LLC is a Delaware limited liability company

Mr. Joffe and Mr. Duke are United States citizens

 

(d)Title of Class of Securities:

 

Common Stock

 

(e)CUSIP Number:

 

15870P307

 

Item 3.If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

 

Not applicable. Filed pursuant to Rule 13d-1(c). 

 

 

Item 4.Ownership.

 

   

West Elk

Partners, LP

West Elk,

LLC

West Elk

Capital, LLC

 Jason Joffe

Morgan

Duke

(a) Amount Beneficially Owned: 882,581 882,581 882,581 882,581 882,581
(b) Percent of Class: 6.49% 6.49% 6.49% 6.49% 6.49%
(c) Number of Shares to Which Reporting Person Has:          
  (i) Sole Voting Power: N/A N/A N/A N/A N/A
  (ii) Shared Voting Power: 882,581 882,581 882,581 882,581 882,581
  (iii) Sole Dispositive Power: N/A N/A N/A N/A N/A
  (iv) Shared Dispositive Power: 882,581 882,581 882,581 882,581 882,581

 

The reported shares are the Issuer’s common stock.

 

All of the reported shares are owned directly by West Elk Partners, LP (“West Elk Partners”), whose general partner is West Elk, LLC (the “General Partner”) and whose investment adviser is West Elk Capital, LLC (the “Investment Adviser”). The General Partner and the Investment Adviser could each be deemed to be indirect beneficial owners of the reported shares, and could be deemed to share such beneficial ownership with West Elk Partners.

 

Jason Joffe and Morgan Duke are the managers of the General Partner and Investment Adviser, and could be deemed to share such indirect beneficial ownership with the General Partner, the Investment Adviser, and West Elk Partners.

 

Item 5.Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

 

Item 6.Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable. 

 

Item 7.Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not applicable.

 

 

Item 8.Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9.Notice of Dissolution of Group.

 

Not applicable.

 

Item 10.Certification.

 

By signing below, each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

Signature

 

After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies that the information set forth in this Statement is true, complete and correct.

 

  Date: November 14, 2024  

 

 

WEST ELK PARTNERS, LP

  
       
  By:

West Elk, LLC, General Partner

  
       
  By:

/s/ Jason Joffe

  
  Name:

Jason Joffe

  
  Title:

Manager

  
       
  Date: November 14, 2024  

 

 

WEST ELK, LLC

  
       
  By:

/s/ Jason Joffe

  
  Name:

Jason Joffe

  
  Title:

Manager

  
       
  Date: November 14, 2024  

 

 

WEST ELK CAPITAL, LLC

  
       
  By:

/s/ Jason Joffe

  
  Name:

Jason Joffe

  
  Title:

Manager

  
       
  Date: November 14, 2024  

 

  /s/ Jason Joffe  
  Jason Joffe  

 

  Date: November 14, 2024  

 

  /s/ Morgan Duke  
  Morgan Duke  

 

Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Champions Oncology Charts.
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Champions Oncology Charts.